Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocin-diabetic rats by activating AMPK

CONTEXT: Ellagic acid (EA) is used in traditional medicine to treated hyperlipidaemia. OBJECTIVE: This study examined if AMPK mediates the anti-steatotic effect of ellagic acid (EA) in streptozotocin (STZ)-induced type 1 diabetes mellitus in rats. MATERIALS AND METHODS: Adult male Wistar rats (130 ±...

Descripción completa

Detalles Bibliográficos
Autores principales: ALTamimi, Jozaa Z., Alshammari, Ghedeir M., AlFaris, Nora A., Alagal, Reham I., Aljabryn, Dalal H., Albekairi, Norah A., Alkhateeb, Mahmoud Ahmad, Yahya, Mohammed Abdo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654409/
https://www.ncbi.nlm.nih.gov/pubmed/34870551
http://dx.doi.org/10.1080/13880209.2021.1990969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654409/
https://www.ncbi.nlm.nih.gov/pubmed/34870551
http://dx.doi.org/10.1080/13880209.2021.1990969

Ejemplares similares